Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2021 Filed May 27, 2021 20:50 UTC |
Wilson John RobertDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0000899243-21-020864 · doc4.xml · derivative · entry 3 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-24 F4 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:47 UTC |
Bornstein Jeffrey SDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0000899243-21-020863 · doc4.xml · derivative · entry 1 Bornstein Jeffrey S · CIK 0001579989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-24 F1 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:47 UTC |
Vera JuanDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0000899243-21-020862 · doc4.xml · derivative · entry 1 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-24 F1 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:45 UTC |
Jovan-Embiricos MoranaDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0000899243-21-020859 · doc4.xml · derivative · entry 1 Jovan-Embiricos Morana · CIK 0001575745 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-24 F1 · derivative.exercise_date: This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| May 18, 2021 Filed Sep 20, 2021 22:33 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 15,201 | $22.80 | $346,582.80 |
DisclosureSEC source: 0000899243-21-036636 · doc4.xml · nonDerivative · entry 3 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,321 F1 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 17, 2021 Filed May 18, 2021 17:08 UTC |
Brainard DianaDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $23.74 | $0.00 |
DisclosureSEC source: 0000899243-21-019779 · doc4.xml · derivative · entry 3 Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2031-05-17 F3 · derivative.exercise_date: 25% of this option shall vest and become exercisable on May 17, 2022, with the remainder vesting in twelve quarterly installments thereafter. Read SEC document |
| May 17, 2021 Filed May 18, 2021 17:08 UTC |
Brainard DianaDirector · Chief Executive Officer
|
GrantCommon Stock | 170,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019779 · doc4.xml · nonDerivative · entry 2 Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,300 F2 · shares: The shares reported in this transaction represent RSUs issued under the Plan. 25% of these RSUs shall vest on May 17, 2022, with the remainder vesting in twelve quarterly installmenters thereafter. Read SEC document |
| May 17, 2021 Filed May 18, 2021 17:08 UTC |
Brainard DianaDirector · Chief Executive Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019779 · doc4.xml · nonDerivative · entry 1 Brainard Diana · CIK 0001818070 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on May 17, 2022. Read SEC document |
| May 10, 2021 Filed May 10, 2021 21:28 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 150,000 | $22.75 | $3,412,500.00 |
DisclosureSEC source: 0001209191-21-031337 · doc4.xml · nonDerivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,309,142 F1 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 05, 2021 Filed Sep 20, 2021 16:05 UTC |
Melian AgustinChief Medical Officer
|
SaleCommon Stock | 18,212 | $23.89 | $435,084.68 |
DisclosureSEC source: 0000899243-21-036577 · doc4.xml · nonDerivative · entry 1 Melian Agustin · CIK 0001818064 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,304 F1 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 16:53 UTC |
Melian AgustinChief Medical Officer
|
SaleCommon Stock | 3,750 | $25.97 | $97,393.50 |
DisclosureSEC source: 0001209191-21-022860 · doc4.xml · nonDerivative · entry 1 Melian Agustin · CIK 0001818064 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,516 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.52 to $26.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 21:08 UTC |
Leen Ann M.Chief Scientific Officer
|
SaleCommon Stock | 3,025 | $30.00 | $90,750.91 |
DisclosureSEC source: 0001209191-21-021808 · doc4.xml · nonDerivative · entry 1 Leen Ann M. · CIK 0001763026 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,459,142 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.95 to $30.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 769 | $31.63 | $24,321.70 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 14 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,164,954 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.22 to $32.125. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 2,308 | $31.63 | $72,996.73 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 13 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,412,953 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.22 to $32.125. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 3,397 | $30.87 | $104,875.58 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 12 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,165,723 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.22 to $31.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 10,188 | $30.87 | $314,535.14 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 11 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,415,261 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.22 to $31.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 300 | $32.31 | $9,693.51 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 10 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,169,120 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.275 to $32.325. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 900 | $32.31 | $29,080.53 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 9 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,425,449 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.275 to $32.325. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 8,418.75 | $31.59 | $265,973.57 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 8 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,169,420 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.18 to $32.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 25,256.25 | $31.59 | $797,920.71 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 7 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,426,349 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.18 to $32.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 9,467.25 | $30.93 | $292,806.89 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 6 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,177,838.75 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.18 to $31.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 28,402.75 | $30.93 | $878,448.77 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 5 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,451,605.25 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.18 to $31.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 10,169 | $31.70 | $322,317.64 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 4 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,187,306 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.58 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 30,506 | $31.70 | $966,921.23 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 3 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,480,008 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.58 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 17,480 | $31.30 | $547,052.33 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 2 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,197,475 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.58 to $31.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F6 · ownership.nature: Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:43 UTC |
Wilson John RobertDirector
|
SaleCommon Stock | 52,440 | $31.30 | $1,641,157.00 |
DisclosureSEC source: 0000899243-21-011155 · doc4.xml · nonDerivative · entry 1 Wilson John Robert · CIK 0001755569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,510,514 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.58 to $31.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 701 | $34.40 | $24,116.92 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 9 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 818,663 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.01 to $34.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 2,300 | $33.31 | $76,604.49 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 8 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 819,364 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.90 to $33.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 6,141 | $32.19 | $197,669.58 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 7 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 821,664 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 15,289 | $31.27 | $478,074.80 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 6 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 827,805 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.90 to $31.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 23,660 | $30.39 | $719,034.50 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 5 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 843,094 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.90 to $30.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 10,947 | $37.41 | $409,554.64 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 4 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 866,754 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.07 to $37.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 8,814 | $36.58 | $322,404.66 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 3 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 877,701 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.06 to $37.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 13,876 | $35.46 | $492,024.92 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 2 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 886,515 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.06 to $36.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:12 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 15,961 | $34.67 | $553,313.60 |
DisclosureSEC source: 0001209191-21-018532 · doc4.xml · nonDerivative · entry 1 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 900,391 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.06 to $35.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 03, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 8,500 | $38.53 | $327,471.85 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 8 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 916,352 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.30 to $38.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 03, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 6,032 | $37.73 | $227,616.92 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 7 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 924,852 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.29 to $38.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 03, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 3,383 | $36.91 | $124,861.12 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 6 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 930,884 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.29 to $37.285. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 7,546 | $38.63 | $291,517.83 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 9 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,339,928 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.50 to $38.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 7,142 | $38.22 | $272,953.67 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 8 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,347,474 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.50 to $38.495. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 1,300 | $37.01 | $48,113.52 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 7 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,354,616 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.50 to $37.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 1,614 | $39.14 | $63,172.77 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 5 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 934,267 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.89 to $39.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 7,317 | $38.27 | $280,016.47 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 4 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 935,881 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.87 to $38.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 3,727 | $37.35 | $139,198.98 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 3 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 943,198 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.845 to $37.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 1,803 | $39.10 | $70,500.00 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 6 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,355,916 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.84 to $39.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 9,001 | $38.30 | $344,707.70 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 5 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,357,719 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.84 to $38.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:36 UTC |
Vera JuanDirector
|
SaleCommon Stock | 4,190 | $37.28 | $156,188.54 |
DisclosureSEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 4 Vera Juan · CIK 0001755495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,366,720 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.84 to $37.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2021 Filed Sep 20, 2021 22:33 UTC |
VAN BEEK JEROEN BChief Commercial Officer
|
SaleCommon Stock | 512 | $37.93 | $19,420.16 |
DisclosureSEC source: 0000899243-21-036636 · doc4.xml · nonDerivative · entry 2 VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,522 F1 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person. F2 · balance_after: As previously reported, the reporting person sold 17,100 shares of Common Stock between February 17, 2021 and March 2, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 8,869 | $39.00 | $345,899.87 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 2 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 946,925 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.61 to $39.585. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:34 UTC |
Brenner MalcolmDirector
|
SaleCommon Stock | 12,825 | $38.39 | $492,327.38 |
DisclosureSEC source: 0001209191-21-017524 · doc4.xml · nonDerivative · entry 1 Brenner Malcolm · CIK 0001818068 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 955,794 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.61 to $38.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.